Antonio Capalbo Ph.D., M.Sc is Chief Scientific Officer for Juno Genetics.
Dr. Capalbo received his Bachelor of Science degree in Biotechnology from University of Rome ‘La Sapienza’ and his Ph.D. magna cum laude in Human Genetics at the Catholic University of Sacred Heart of Rome in 2011. He obtained a Master’s Degree in Epidemiology and Biostatistical data analysis at Catholic University of Sacred Heart of Rome in 2011.
From 2008 to 2012 Dr. Capalbo has been working as a clinical embryologist, pioneering embryo biopsy approaches and applications. Since then, his research has focused on preimplantation genetic testing and on the development of novel molecular biology techniques to improve pregnancy and take-home baby rates in ART. His basic research has been focused on the mechanisms of aneuploidies in oocytes and preimplantation human embryos. He received several grants for innovative studies on these subjects. From 2012-2022 he has been co-founder and director of the largest PGT program in Italy and Europe.
He is currently coordinator of the ESHRE SIG in Reproductive Genetics, member of the genomics-working group of the Italian society of human genetics, and Chief Scientific Officer (CSO) at Juno Genetics.
He has published more than 100 peer-reviewed papers and book chapters and is currently Associated Editor for Human Reproduction Journal and section editor of RBM Online Journal. Furthermore he is ad hoc reviewer for many Journals in the field of reproductive biology and genetics (New England Journal of Medicine, American Journal of Human Genetics, Human Reproduction Update, Fertility and Sterility, , Journal of Assisted Reproduction and Genetics, Journal of Medical Genetics, Scientific Reports, PNAS).